An insider at Xenon Pharma has sold $78,000 worth of shares, coinciding with a substantial 55% increase in the company's stock price.

Several stocks, including Hims & Hers Health, oil stocks, and Live Nation Entertainment, are making significant moves in premarket trading, with Hims & Hers specifically upgraded to Buy from Hold by Needham.

Xenon Pharmaceuticals has announced a proposed public offering, which typically involves selling new shares to raise capital for company operations or expansion.

Dianthus Therapeutics has announced the pricing of its upsized public offering, raising $625 million with shares priced at $81 each.